High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$722K
$722,624
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| LXRX |
LEXICON PHARMACEUTICALS, INC.
|
Director
Discretionary Buy
|
2026-02-25 | $2,980 | P | Form 4 |
|
LXRX
P
LEXICON PHARMACEUTICALS, INC.
DEBBANE RAYMOND
• Director
Discretionary Buy
2026-02-23
$147,000
|
||||||
| LXRX |
LEXICON PHARMACEUTICALS, INC.
|
Director
Discretionary Buy
|
2026-02-23 | $147,000 | P | Form 4 |
|
LXRX
P
LEXICON PHARMACEUTICALS, INC.
DEBBANE RAYMOND
• Director
Discretionary Buy
2026-02-20
$147,790
|
||||||
| LXRX |
LEXICON PHARMACEUTICALS, INC.
|
Director
Discretionary Buy
|
2026-02-20 | $147,790 | P | Form 4 |
|
LXRX
P
LEXICON PHARMACEUTICALS, INC.
DEBBANE RAYMOND
• Director
Discretionary Buy
2026-02-19
$71,965
|
||||||
| LXRX |
LEXICON PHARMACEUTICALS, INC.
|
Director
Discretionary Buy
|
2026-02-19 | $71,965 | P | Form 4 |
|
LXRX
P
LEXICON PHARMACEUTICALS, INC.
DEBBANE RAYMOND
• Director
Discretionary Buy
2026-02-18
$176,468
|
||||||
| LXRX |
LEXICON PHARMACEUTICALS, INC.
|
Director
Discretionary Buy
|
2026-02-18 | $176,468 | P | Form 4 |
|
LXRX
P
LEXICON PHARMACEUTICALS, INC.
DEBBANE RAYMOND
• Director
Discretionary Buy
2026-02-17
$100,544
|
||||||
| LXRX |
LEXICON PHARMACEUTICALS, INC.
|
Director
Discretionary Buy
|
2026-02-17 | $100,544 | P | Form 4 |
|
LXRX
P
LEXICON PHARMACEUTICALS, INC.
DEBBANE RAYMOND
• Director
Discretionary Buy
2026-02-13
$75,877
|
||||||
| LXRX |
LEXICON PHARMACEUTICALS, INC.
|
Director
Discretionary Buy
|
2026-02-13 | $75,877 | P | Form 4 |